Laboratorio Rontag

What Laboratorio Rontag does

Laboratorio Rontag S.A. is a privately held Argentine pharmaceutical laboratory (Sociedad Anónima) that develops, manufactures, and distributes branded generic prescription and over-the-counter medications across multiple therapeutic areas including neurology and psychiatry (Levetiracetam/Levron, Aripiprazole/Arlemide, Modafinil/Intensit), otology and vestibular disorders (the Ronistina betahistine line for vertigo and Ménière's disease), hematology (the Yectafer iron-supplement line), pain and inflammation (the Naprontag naproxen line, Deflazacort/DEFAS, Nalbuphine/Nubaina), and immunology/rheumatology (Leflunomide/Lefluar, Hydroxychloroquine/Axokine, Azathioprine). The portfolio comprises approximately 25+ products, each marketed under a distinct brand name corresponding to a generic active ingredient.

The company operates a sales-led go-to-market with a hybrid community-led layer: products are distributed through Argentine pharmacy networks under commercial terms negotiated by an in-house sales department, while healthcare-professional engagement is sustained through themed newsletters (covering ORL, Neurology, Rheumatology, Clinical Practice, Hematology, and Gynecology-Obstetrics), webinars, and educational resources on conditions such as iron deficiency, vestibular disorders, epilepsy, and pain. The firm co-hosts educational events with medical associations including AMyCA (Asociación Migraña y Cefaleas Argentina) for migraine management, and operates a pharmacovigilance channel. All products are regulated by ANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).

The business model is a one-time product-sale revenue model: pharmaceutical units are sold once to pharmacies (and through them to end patients) with discounts and commercial conditions handled directly by the sales department. Pricing is not publicly disclosed. Geographic reach is single-country (Argentina), with active presence on Instagram and LinkedIn. No app, API, or digital platform product layer exists; the company has no disclosed funding rounds, parent company, subsidiaries, leadership team details, or founding date.

Name

Laboratorio Rontag

Legal name

Laboratorio Rontag S.A.

Website

https://rontag.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

Laboratorio Rontag S.A. is a private Argentine pharmaceutical laboratory that develops and distributes approximately 25+ branded generic medications across neurology, vestibular, hematology, rheumatology, and pain, selling through domestic pharmacy networks to patients via healthcare professionals.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIABAL

Generic Hospital & Institutional Products

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIADAA

Pain Relief & Anti-Inflammatory (Analgesics)

Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

• Generic pharmaceuticals
• Neurology medications
• Vestibular disorder treatments
• Iron deficiency supplements
• Anti-inflammatory drugs

Headquarters

HQ city

Vicente López

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Laboratory sells prescription and over-the-counter generic medications through pharmacy distribution. Products cover multiple therapeutic areas including CNS disorders, iron supplementation, anti-inflammatory medications, and immunological products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Laboratorio Rontag is an Argentine pharmaceutical laboratory that develops, manufactures, and distributes branded generic medications across multiple therapeutic areas including neurology and psychiatry, vestibular disorders, hematology (iron deficiency), pain and inflammation, rheumatology, immunology, and infectious diseases. The company sells its prescription and OTC products through pharmacy distribution networks, supported by medical education programs for healthcare professionals and pharmacovigilance services.

Product overview

Laboratorio Rontag is an Argentine pharmaceutical laboratory with a broad portfolio of prescription and over-the-counter medications spanning multiple therapeutic areas including neurology/psychiatry (Arlemide, Intensit, Levron), otology/vestibular disorders (Ronistina line with Betahistina), pain/inflammation (Naprontag line, DEFAS), immunology/rheumatology (Axokine, Azatioprina, Lefluar), infectious diseases (Daps), and hematology (Yectafer line for iron deficiency). The company also provides educational resources for healthcare professionals and patients, operates pharmacovigilance programs, and distributes through pharmacies. The product portfolio includes branded generics and specialized formulations across approximately 25+ products.

Differentiator

Problem solved

Functional benefit

Brands

• Ronistina: Betahistine product line for vestibular disorders including Ronistina, Ronistina Dúo, and Ronistina Dúo MD variants
• Yectafer
• Naprontag
• Arlemide
• Levron
• Intensit
• DEFAS
• Axokine
• Ampakine
• Analerg
• DAPS
• Lefluar
• Modina
• Nubaina
• Rasax
• Serlina
• Solfidin

Products and services

• Ronistina (Betahistina) Betahistine-based medication for vertigo and vestibular disorders including Ménière's disease. Sold through Argentine pharmacies as a prescription product.
• Ronistina Dúo (Betahistina) Dual-action betahistine formulation for vestibular disorders. Distributed through pharmacies in Argentina.
• Ronistina Dúo MD (Betahistina) Betahistine 24mg multi-dose formulation for Ménière's syndrome and vestibular symptoms. Available via Argentine pharmacy distribution.
• Yectafer (Hierro) Iron supplement medication for iron deficiency and iron deficiency anemia. Distributed via Argentine pharmacies.
• Yectafer Complex (Hierro) Iron complex formulation with additional components for enhanced iron absorption and treatment of iron deficiency anemia. Sold through pharmacies.
• Yectafer Tabs (Hierro) Iron tablet formulation for iron deficiency treatment. Available through pharmacy distribution in Argentina.
• Naprontag (Naproxeno) Naproxen-based NSAID for pain and inflammation relief. Distributed through Argentine pharmacies.
• Naprontag 24 (Naproxeno) Extended-release naproxen formulation for 24-hour pain relief. Sold via pharmacy channels.
• Naprontag Gesic (Naproxeno) Naproxen formulation for pain relief. Available through Argentine pharmacy distribution.
• Levron (Levetiracetam) Antiepileptic medication containing levetiracetam for seizure control. Prescription product distributed via pharmacies.
• Intensit (Modafinilo) Modafinil-based medication for narcolepsy and excessive daytime sleepiness. Available via Argentine pharmacy distribution.
• Arlemide (Aripiprazol) Aripiprazole-based antipsychotic medication for psychiatric disorders including schizophrenia and depression. Sold through pharmacies.
• Lefluar (Leflunomida) Leflunomide-based medication for rheumatoid arthritis and psoriatic arthritis. Distributed via pharmacies.
• Axokine (Hidroxicloroquina) Hydroxychloroquine-based medication used for autoimmune conditions and malaria. Sold through Argentine pharmacies.
• Azatioprina Rontag (Azatioprina) Immunosuppressive medication containing azathioprine for autoimmune diseases. Distributed via pharmacies.
• Modina (Fingolimod) Fingolimod-based medication for multiple sclerosis. Available through Argentine pharmacy distribution.
• DEFAS (Deflazacort) Corticosteroid medication containing deflazacort, indicated for inflammatory and autoimmune conditions including Duchenne muscular dystrophy. Sold via pharmacies.
• Analerg (Levocetirizina) Levocetirizine-based antihistamine for allergic conditions. Distributed through Argentine pharmacies.
• DAPS (Dapsona) Dapsone-based medication used primarily for leprosy and dermatitis herpetiformis. Available through pharmacy distribution.
• Ampakine (Amantadina) Pharmaceutical product containing amantadine, used for specified therapeutic indications. Sold through Argentine pharmacies.
• Nubaina (Nalbufina) Nalbuphine-based analgesic medication. Distributed via Argentine pharmacies for pain management.
• Rasax Pharmaceutical product for psychiatric/neurological use. Available through Argentine pharmacy distribution.
• Serlina Pharmaceutical product for psychiatric use. Distributed via Argentine pharmacies.
• Solfidin Pharmaceutical product for sleep disorders. Available through pharmacy distribution in Argentina.
• Solfidin Flash Fast-acting formulation of Solfidin for sleep disorders. Distributed via Argentine pharmacies.

Quantifiable outcome

• Treatment success rates mentioned: Conservative treatment achieves control in 60-87% of Ménière's disease cases; betahistina Level A evidence as antivertiginous in neurotology

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Asociación Migraña y Cefaleas Argentina (AMyCA)coreStrategic or Co-development Partner · 18 February 2026Collaborative partnership for healthcare professional education. Jointly conducted a webinar on 'Manejo de Migraña en 3 simples pasos' (Migraine Management in 3 Simple Steps), an educational update and training session focused on the practical approach to this high-prevalence pathology.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Laboratorios Roemmers: Argentine pharmaceutical laboratory with an extensive branded-generic and specialty prescription portfolio (CNS, cardiology, rheumatology, etc.) sold through Argentine pharmacies under ANMAT regulation; same domestic generic-pharma playbook as Rontag with broader scale.
• Laboratorios Baliarda: Argentine pharmaceutical laboratory with branded generics in CNS, cardiology, and rheumatology; comparable ANMAT-regulated domestic generic-pharma peer selling through pharmacy networks.
• Laboratorios Beta: Argentina-based pharma laboratory with a specialty generics portfolio across CNS, pain, and hematology; comparable ANMAT-regulated domestic manufacturer/distributor with similar therapeutic footprint to Rontag.
• Laboratorios Raffo: Argentine pharmaceutical manufacturer with a specialty generics portfolio in oncology, neurology, and immunology; comparable to Rontag as a mid-sized domestic ANMAT-regulated pharma with branded-generic formulations.
• Laboratorios Gador: Argentina-based pharma lab specializing in branded generics across neurology, psychiatry, rheumatology, and pain — overlapping Rontag's core therapeutic areas and also relying on physician-targeted promotion and pharmacy distribution.
• Laboratorios Casasco: Argentine pharma laboratory focused on branded generics in CNS, respiratory, and pain — overlapping Rontag's therapeutic mix and pharmacy channel.
• Laboratorios Bagó: One of Argentina's largest privately-held pharmaceutical laboratories, marketing branded generics and specialty pharma across CNS, pain, rheumatology and other therapeutic areas through pharmacy networks — directly comparable to Rontag's business model, therapeutic mix, and ANMAT-regulated domestic distribution approach.
• Laboratorios Richmond: Argentine pharmaceutical company producing branded generics and specialty drugs across multiple therapeutic areas, regulated by ANMAT and distributed through pharmacies — comparable mid-tier domestic generic-pharma peer.

Broad incumbents

• Laboratorios Elea Phoenix: Major Argentine pharma resulting from the merger of Laboratorios Elea and Laboratorios Phoenix; one of the leading domestic branded-generic players in CNS, gynecology, and cardiovascular, with portfolio breadth overlapping Rontag.
• Teva Argentina: Argentine subsidiary of Teva Pharmaceutical Industries, the world's largest generic drugmaker; directly competes with Rontag on many of the same molecules (levetiracetam, naproxen, betahistine, hydroxychloroquine) in the Argentine market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/laboratorio-rontag-s-a
• Instagraminstagram.com/laboratoriorontag

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorio Rontag